Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19ARF) and is amplified in a subset of human breast cancers
Nature Genetics2000Vol. 26(3), pp. 291–299
Citations Over TimeTop 10% of 2000 papers
Jacqueline J.L. Jacobs, Petra Keblusek, Els C. Robanus-Maandag, Petra Kristel, Merel Lingbeek, Petra M. Nederlof, Tibor van Welsem, Marc J. van de Vijver, Eugene Y. Koh, George Q. Daley, Maarten van Lohuizen
Related Papers
- → Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling(2019)34 cited
- → CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma(2014)56 cited
- → Kinetic Mechanisms of Mutation-Dependent Harvey Ras Activation and Their Relevance for the Development of Costello Syndrome(2013)50 cited
- → Targeted molecular profiling reveals genetic heterogeneity of poromas and porocarcinomas(2017)41 cited
- → Ultra-deep targeted sequencing to identify HRAS, TP53, and CDKN2A somatic mutations as molecular prognostic markers in patients with advanced oral squamous cell carcinoma.(2015)